Background Artificial intelligence ECG (AI-ECG) models can predict cardiovascular outcomes, but their clinical adoption is limited by restricted access to training data and uncertain generalisability.
Neuralink is developing brain-computer interface tech to aid mobility in paralysis and vision restoration. Neuralink is not publicly traded, limiting stock availability to private, accredited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results